Abstract:Background: Although partial nephrectomy has become the gold standard for T1 renal tumors whenever technically feasible, simple enucleation has shown superior results. To the best of our knowledge, no randomized controlled trials comparing these two surgical approaches have been published. Objective: To compare the surgical margin status for robot-assisted simple enucleation (RASE) and standard robot-assisted partial nephrectomy (sRAPN) for clinical T1 renal tumors. Design, setting, and participants: This is a prospective, randomized, controlled, noninferiority trial. A total of 380 patients aged 18-80 yr with newly diagnosed, sporadic, unilateral clinical T1 renal tumors (RENAL score <10) were enrolled and randomized to RASE or sRAPN. The primary endpoint was the positive surgical margin (PSM) rate, with a noninferiority margin of 7.5% set. The study was registered on ClinicalTrials.gov (NCT03624673). Outcome measurements and statistical analysis: We defined noninferiority for RASE versus standard RAPN as an upper 95% confidence interval (CI) bound of <7.5% for the difference in the proportion of patients with a PSM. Results and limitations: A cohort of 380 patients was enrolled and randomly assigned to RASE (n = 190) or sRAPN (n = 190). On intention-to-treat analysis for patients with malignant tumors, 2.3% of patients in the RASE group and 3.0% in the sRAPN group had a PSM. The RASE group showed noninferiority to the sRAPN group within a 7.5% margin (difference -0.7%, 95% CI -4.0% to 2.7%). Per-protocol analysis also demonstrated noninferiority of RASE. The RASE group had a shorter median operative time (145 vs 155 min; p = 0.018) and a lower rate of tumor bed suturing (8.9% vs 43%; p < 0.001) in comparison to the sRAPN group. Estimated blood loss was considerably lower in the sRAPN group than in the RASE group (p = 0.046). The rate of recurrence did not differ between the groups (p > 0.9). Conclusions: RASE for the management of low- to intermediate-complexity tumors is noninferior to sRAPN in terms of the PSM rate. Long-term follow-up is needed to draw conclusions regarding oncological outcomes. Patient summary: We carried out a trial to compare simple tumor enucleation versus partial nephrectomy for renal tumors. The outcome we assessed was the proportion of patients with a positive surgical margin. Our results show that simple tumor enucleation is not inferior to partial nephrectomy for this outcome. Longer follow-up is needed to assess other cancer control outcomes. (c) 2023 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

MP21-20 WHOLE-MOUNT PATHOLOGY OF RENAL TUMOR SPECIMENS IMPROVES THE DIAGNOSIS OF RENAL CANCER:THE PRELIMINARY RESULTS

Our Experience of Partial Nephrectomy for Renal Carcinoma:The Role and Proper Surgical Margin

Retroperitoneal laparoscopic nephron-sparing surgery for renal tumor:report of 15 cases

Technical Improvements in Open Radical Nephrectomy with Renal Carcinoma

Tumor Enucleation Vs. Partial Nephrectomy for T1 Renal Cell Carcinoma: A Systematic Review and Meta-Analysis

Positive Surgical Margins in Renal Cell Carcinoma

Robotic Partial Nephrectomy: Current Technique and Outcomes

Retroperitoneal Laparoscopic Nephrotomy along the Brodel Line and Tumor Enucleation for Complete Intraparenchymal Renal Tumors: A Single Institution Experience

Positive Surgical Margins After Partial Nephrectomy For Renal Cell Carcinoma: A Systematic Review And Meta-Analysis

The Prognostic Impact of the Surgical Margin in Renal Cell Carcinoma Treated with Partial Nephrectomy: A Multi-Center Study

Technique of ultra-thin parenchyma layer resection in robotic partial nephrectomy for renal tumor via retroperitoneal approach: our experience (Report of 58 cases)

Robot-assisted Simple Enucleation Versus Standard Robot-assisted Partial Nephrectomy for Low- or Intermediate-complexity, Clinical T1 Renal Tumors: A Randomized Controlled Noninferiority Trial.

Clinical Analysis of Nephron-sparing Surgery for T1 Stage Renal Cell Carcinoma(Report of 98 cases)

Time trends in surgical provision and cancer-specific outcomes in patients with stage T2-3 kidney cancer: a SEER-based study

Comparison Studies of "Ultrathin Parenchyma" Resection and Sharp Dissection in Robotic Partial Nephrectomy for Renal Tumors

Quantifying preserved renal volume and function in patients undergoing standard partial nephrectomy vs. tumor enucleation for localized renal tumors

Single institutional experience of neoadjuvant therapy prior to planned surgical resection for complex or locoregional renal cell carcinoma.

Long-Term Oncologic Outcomes After Laparoscopic and Robotic Tumor Enucleation for Renal Cell Carcinoma

PD11-04 COMPARING ENDOSCOPIC ROBOT-ASSISTED SIMPLE ENUCLEATION AND STANDARD ROBOT-ASSISTED PARTIAL NEPHRECTOMY FOR T1 RENAL CELL CARCINOMA: INITIAL RESULTS OF A NON-INFERIORITY RANDOMIZED CONTROLLED TRIAL

"To Be or Not to Be Benign" at Partial Nephrectomy for Presumed RCC Renal Masses: Single-Center Experience with 195 Consecutive Patients

Clinical study of laporoscopic nephron sparing surgery for T1 renal cell carcinoma